HUBS vs IMRX · P/E 96, rev $1.79B vs $124.2M cap
HubSpot Inc (HUBS) versus Immuneering Corp (IMRX) — a side-by-side from cached financials, not a winner call.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
IMRX does not have a complete income-statement cache yet.
HUBS currently screens at market cap $9.36B and trailing P/E 96.2. IMRX currently screens at market cap $124.2M.
Not investment advice. Open the HUBS and IMRX stock pages for the full models.
Not investment advice.